|
Lopez-Galvez R, Marin F, Rivera-Caravaca JM. Predicting heart failure in atrial fibrillation patients: What about using biomarkers? Am Heart J. 2022 Sep;251:32-34. doi: 10.1016/j.ahj.2022.05.007. Epub 2022 May 7. No abstract available. PubMed PMID: 35537504.
AÑO: 2022; IF: 4.8
|
35537504
|
Ramirez-Macias I, Orenes-Pinero E, Camelo-Castillo A, Rivera-Caravaca JM, Lopez-Garcia C, Marin F. Novel insights in the relationship of gut microbiota and coronary artery diseases. Crit Rev Food Sci Nutr. 2022;62(14):3738-3750. doi: 10.1080/10408398.2020.1868397. Epub 2021 Jan 5. PubMed PMID: 33399007.
AÑO: 2022; IF: 10.2
|
|
Roldan V, Martinez-Montesinos L, Lopez-Galvez R, Garcia-Tomas L, Lip GYH, Rivera-Caravaca JM, Marin F. Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists. J Pers Med. 2022 Mar 17;12(3):487. doi: 10.3390/jpm12030487. PubMed PMID: 35330486; PubMed Central PMCID: PMC8954236.
AÑO: 2022; IF: 3.508
|
|
Rivera-Caravaca JM, Lip GYH, Roldan V, Marin F. Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system. Front Cardiovasc Med. 2022 Oct 17;9:1042728. doi: 10.3389/fcvm.2022.1042728. eCollection 2022. No abstract available. PubMed PMID: 36324744; PubMed Central PMCID: PMC9619039.
AÑO: 2022; IF: 3.6
|
|
Ding WY, Rivera-Caravaca JM, Marin F, Li G, Roldan V, Lip GYH. Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world vs. clinical-trial evidence. Br J Clin Pharmacol. 2022 Jan;88(1):282-289. doi: 10.1111/bcp.14961. Epub 2021 Jul 13. PubMed PMID: 34192808.
AÑO: 2022; IF: 3.4
|